Kaehler, Katharina C.; Gutzmer, Ralf; Meier, Friedegrund et al.
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG StudyFRONTIERS IN ONCOLOGY. Bd. 11. 2021
Bhari, Neetu; Schwaertz, Robert A.; Apalla, Zoe et al.
Effect of estrogen in malignant melanomaJOURNAL OF COSMETIC DERMATOLOGY. Bd. 21. H. 5. 2021 S. 1905-1912
Rokni, G. Rahmatpour; Shiran, M.; Abounoori, M. et al.
Effects of metformin on autoimmune immunoglobins and interferon-gamma in patients with early diagnosed pemphigus vulgaris: a prospective clinical trialCLINICAL AND EXPERIMENTAL DERMATOLOGY. Bd. 47. H. 1. 2021 S. 110-113
Kocaturk, Emek; Al-Ahmad, Mona; Krause, Karoline et al.
Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE studyALLERGY. Bd. 76. H. 10. 2021 S. 3133-3144
Rudnicka, Lidia; Olszewska, Malgorzata; Goldust, Mohamad et al.
Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and OintmentJOURNAL OF CLINICAL MEDICINE. Bd. 10. H. 23. 2021
Rokni, Ghasem Rahmatpour; Mohammadnezhad, Farzaneh; Saeedi, Majid et al.
Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single-blinded, active-controlled trialJOURNAL OF COSMETIC DERMATOLOGY. Bd. 20. H. 11. 2021 S. 3580-3585
Li, Mengyi; Jiang, Shuai; Haller, Adelina et al.
Encapsulation of polyprodrugs enables an efficient and controlled release of dexamethasoneNANOSCALE HORIZONS. Bd. 6. H. 10. 2021 S. 791-800
Staubach, Petra; Mann, Caroline; Peveling-Oberhag, Adriane et al.
Epidemiology of urticaria in German childrenJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2021
Riegel, Kristina; Yurugi, Hajime; Schloeder, Janine et al.
ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppressionCELL DEATH & DISEASE. Bd. 12. H. 11. 2021
Hrgovic, Igor; Kleemann, Johannes; Doll, Monika et al.
Evaluation of 2-methoxyestradiol scrum levels as a potential prognostic marker in malignant melanomaMOLECULAR AND CLINICAL ONCOLOGY. Bd. 15. H. 1. 2021